TROG 91.01 - Head & Neck - Accelerated RT

By w.paterson
August 15, 2021
0 Comments

A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Participating Centres

Current Accrual

February 28, 2022

Cancer trial participant hoping to help

The RAVES trial treating prostate cancer Participating in a

June 15, 2021

Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery

Ductal carcinoma in situ (DCIS) of the breast is

For over 30 years, TROG Cancer Research has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

TROG 92.01 – PCNSL (Phase II)

TROG 89.04 – Oesophageal – Synchronous RT & CT

Related Post

Cancer trial participant hoping to help

Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery

TROG Cancer Research © 2022. All rights reserved

Website developed by the Marketing GP

TROG 91.01 – Head & Neck – Accelerated RT

A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

TROG 92.01 – PCNSL (Phase II)

TROG 89.04 – Oesophageal – Synchronous RT & CT

Related Post

Cancer trial participant hoping to help

Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery